Søgning på udtrykket 'hepatitis b' giver 53 resultater


Dokumenter [5] Sider [2] Kalender [5] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [5]

Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).

National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.

Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner. Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Se…

Sider [2]

…: Anne Øvrehus (tovholder), Peer Brehm Christensen, Nina Weis, Britta Tarp, Lone Mygind National Strategi for Hepatitis C (Sundhedsstyrelsen 2023), Kronisk viral hepatitis: Nina Weis (tovholder), Peer Brehm Christensen, Alex Lund Laursen Hepatitis B (2018), Hepatitis C (2022), HIV: Antiretroviral terapi: Jan Gerstoft (tovholder), Jens Lundgren, Henrik Nielsen, Alex Laursen, Niels Obel, Isik Somuncu, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smi…

Professor Nina Weis kommenterer: Kronisk hepatitis B, forårsaget af forekomst af hepatitis B virus i blodet i > 6 måneder, kan klinisk manifestere sig fra asymptomatisk til fibrose, cirrose og hepatocellulært carcinom. Trods forekomst af en effektiv vaccine i mere end 40 år, lever 296 millioner mennesker globalt med kronisk hepatitis B, heraf estimerede 14.500 i Danmark. Aktuelt er eneste behandlingstilbud (ofte livslang) antiviral terapi. Denne artikel gennemgår naturhistorien, kendte og nye biomark…


Kalender [5]

10. juni, Nielsine Nielsen Auditoriet, Panum, København
17. juni 2022, Auditorium 3+4, Hvidovre Hospital
7. november 2011, Auditorium 93, Rigshospitalet

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Proceedings of the National Academy of Sciences
12.06.2024
Proceedings of the National Academy of Sciences, Volume 121, Issue 24, June 2024.
PLoS One Infectious Diseases
12.06.2024
by Jiwoo Han, Kyung Lib Jang . All-trans retinoic acid (ATRA), recognized as the principal and most biologically potent metabolite of vitamin A, has been identified for its inhibitory effects on hepatitis B virus (HBV) replication. Nevertheless, the underlying mechanism remains elusive. The present study reveals that ATRA induces E6-associated protein (E6AP)-mediated proteasomal degradation of HBx to suppress HBV replication in human hepatoma cells in a p53-dependent pathway. For this effect, ATRA induced …
Journal of Infectious Diseases
8.06.2024
Abstract . Background . Immunological studies on chronic hepatitis B virus (HBV) infection have convincingly shown immune dysfunction involving multiple cell types. The focus of the majority of studies has been on the role of T cells and showed an impaired functional T cell response to HBV. B cells have been evaluated more recently, but in contrast to T cells, more pronounced activation of circulating B cells has been reported. To gain more insight into the activation status of B cells, we investigated the …
Journal of Medical Virology
4.06.2024
Journal of Medical Virology, Volume 96, Issue 6, June 2024.
Clinical Infectious Diseases
30.05.2024
Abstract . Objective . International guidelines recommend maternal tenofovir disoproxil fumarate (TDF) therapy accompanied by infant immunoprophylaxis to prevent HBV mother-to-child transmission (MTCT) in highly viremic mothers. However, pooled analyses for tenofovir alafenamide (TAF) effects and comparisons between the two regimens are lacking.Design . In this meta-analysis, pairs of independent reviewers performed multiple database searches from inception to March 31, 2024, and extracted data from cohort …
Journal of Medical Virology
29.05.2024
Journal of Medical Virology, Volume 96, Issue 6, June 2024.
PLoS One Infectious Diseases
23.05.2024
…an, Bo Wang, Di Mu, Juan Chen, Ying Huang, Qin Hu, Weixian Chen . Killer cell lectin-like receptor G1 (KLRG1) has traditionally been regarded as an inhibitory receptor of T cell exhaustion in chronic infection and inflammation. However, its exact role in hepatitis B virus (HBV) infection remains elusive. CD8+ T cells from 190 patients with chronic hepatitis B were analyzed ex vivo for checkpoint and apoptosis markers, transcription factors, cytokines and subtypes in 190 patients with chronic hepatitis B. K…
Journal of Medical Virology
22.05.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
BMJ Open
22.05.2024
. Objectives. To collect and document the numerous barriers that people living with hepatitis B (PLHB) encounter when trying to access their hepatitis B virus (HBV) medications. . Design. Researchers collected qualitative data through 24 online interviews. The semistructured interview questions focused on the impact that HBV has on different aspects of daily life (physical, emotional and social), personal experiences managing their infection, HBV treatment experiences and interactions with healthcare provi…
Journal of Medical Virology
14.05.2024
Journal of Medical Virology, Volume 96, Issue 5, May 2024.
Infection
12.05.2024
. Abstract. . Purpose. Mother-to-child transmission (MTCT) has been the main cause of chronic hepatitis B virus (HBV) infection, particularly in East Asia. Hepatitis B immunoglobulin (HBIG) and vaccination given directly after birth effectively prevents hepatitis B surface antigen (HBsAg)-positive (overt) HBV infection, but occult hepatitis B infection (OBI) may develop despite adequate prophylaxis. The aim of this study was to inve…
Infection
10.05.2024
. Abstract. . Purpose. Mother-to-child transmission (MTCT) has been the main cause of chronic hepatitis B virus (HBV) infection, particularly in East Asia. Hepatitis B immunoglobulin (HBIG) and vaccination given directly after birth effectively prevents hepatitis B surface antigen (HBsAg)-positive (overt) HBV infection, but occult hepatitis B infection (OBI) may develop despite adequate prophylaxis. The aim of this study was to inve…
PLoS One Infectious Diseases
8.05.2024
by Prooksa Ananchuensook, Sirinporn Suksawatamnauy, Panarat Thaimai, Supachaya Sriphoosanaphan, Kessarin Thanapirom, Chinachote Teerapakpinyo, Yong Poovorawan, Piyawat Komolmit .
Clinical Infectious Diseases
6.05.2024
Abstract . This case-control study explored cumulative tenofovir exposure among patients with HIV/HBV co-infection with HIV viral suppression. Among patients taking tenofovir disoproxil fumarate, median TFV-DP levels in dried blood spots were ∼3-fold lower among patients with incomplete HBV viral suppression (n=4) compared to those with complete suppression (n=5) (516 vs.1456 fmol/punch).
Journal of Acquired Immune Deficiency Syndromes
29.04.2024
…TAF) and dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (DTG + F/TDF) achieved high rates of HIV-1 RNA suppression through Week 96 in adults with HIV-1 and hepatitis B virus (HBV) initiating treatment (NCT03547908). Here, we quantify preexisting HIV-1 resistance, evaluate its effect on HIV-1 virologic suppression, and describe postbaseline HIV-1 resistance through Week 96. Methods: . Preexisting HIV-1 resistance was assessed by historical and/or screening genotyping. HIV-1 RNA suppression to
Journal of Infectious Diseases
25.04.2024
Abstract . Background . Hepatitis C virus (HCV) and hepatitis B virus (HBV) cause chronic hepatitis with important clinical differences. HCV causes hepatic steatosis and insulin resistance, while HBV confers increased risk of liver cancer. We hypothesised these differences may be due to virus-specific effects on mitochondrial function.Methods . Seahorse technology was utilised to investigate effects of virus infection on mitochondrial function. Cell based assays were used to measure mitochondrial membrane p…
Journal of Medical Virology
19.04.2024
Journal of Medical Virology, Volume 96, Issue 4, April 2024.
Journal of Infectious Diseases
17.04.2024
Abstract . Background . We evaluated long-term trajectories of circulating hepatitis B virus (HBV)-RNA and hepatitis B core-related antigen (HBcrAg) in persons with and without hepatitis B surface antigen (HBsAg) loss during tenofovir therapy in the Swiss HIV Cohort Study.Methods . We included 29 persons with HIV (PWH) with HBsAg loss and 29 matched PWH without loss. We compared HBV-RNA and HBcrAg decline and assessed the cumulative proportions with undetectable HBV-RNA and HBcrAg levels during tenofovir th…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
15.05.2024
The U.S. drug regulator has declined to approve expanded use of Dynavax Technologies' hepatitis B vaccine in a section of patients, citing insufficient data over destruction. . Reuters Health Information
Eurosurveillance latest updates
28.07.2023
. Background. The burden of chronic hepatitis B virus (HBV) varies across the European Union (EU) and European Economic Area (EEA). . . Aim. We aimed to update the 2017 HBV prevalence estimates in EU/EEA countries and the United Kingdom for 2018 to 2021. . . Methods. We undertook a systematic review, adding to HBV prevalence estimates from an existing (2005–2017) database. Databases were searched for original English-language research articles including HBV surface antigen prevalence estimates among t…
Eurosurveillance latest updates
28.07.2023
. Background. Georgia has adopted the World Health Organization European Region’s and global goals to eliminate viral hepatitis. A nationwide serosurvey among adults in 2015 showed 2.9% prevalence for hepatitis B virus (HBV) surface antigen (HBsAg) and 25.9% for antibodies against HBV core antigen (anti-HBc). HBV infection prevalence among children had previously not been assessed. . . Aim. We aimed to assess HBV infection prevalence among children and update estimates for adults in Georgia. . . Metho…
Morbidity and Mortality Weekly Report (MMWR)
21.07.2023
This report describes progress towards hepatitis B control and elimination in the World Health Organization African region.
Medscape Infectious Diseases
28.06.2023
Vaccination rates for hepatitis B virus are slightly lower among patients with psoriasis than among people without psoriasis. . Medscape Medical News
Medscape Infectious Diseases
11.04.2023
When researchers compared patients who met treatment criteria, treatment initiation was similar across races and socioeconomic status. But that finding raises other questions. . Medscape Medical News
Medscape Infectious Diseases
10.03.2023
The previous risk-based testing approach was not successful at detecting most people living with chronic hepatitis B infection, the agency said. . Medscape Medical News
Eurosurveillance latest updates
9.02.2023
. Background. The World Health Organization European Action Plan 2020 targets for the elimination of viral hepatitis are that > 75% of eligible individuals with chronic hepatitis B (HBV) or hepatitis C (HCV) are treated, of whom > 90% achieve viral suppression. Aim. To report the results from a pilot sentinel surveillance to monitor chronic HBV and HCV treatment uptake and outcomes in 2019. Methods. We undertook retrospective enhanced data collection on patients with a confirme…
Statens Serum Institut
22.12.2022
Antallet af tilfælde med akut hepatitis B er fortsat lavt i Danmark. Kronisk hepatitis B er faldende.
Medscape Infectious Diseases
12.08.2022
Progress has occurred in reducing maternal-to-child transmission of hepatitis B, a leading cause of liver cancer, but is lagging, particularly in Africa. .
Morbidity and Mortality Weekly Report (MMWR)
28.07.2022
This report describes global progress towards the elimination of mother-to-child hepatitis B virus.
Morbidity and Mortality Weekly Report (MMWR)
31.03.2022
This report describes updated hepatitis B vaccination recommendations from the Advisory Committee on Immunization Practices.
Medscape Infectious Diseases
1.03.2022
The three-antigen hepatitis B vaccine received approval from the FDA in November 2021. .
Medscape Infectious Diseases
17.12.2021
With hepatitis B vaccination rates low and infection rates rising, experts hope the new recommendations will raise clinician awareness and simplify screening.
Morbidity and Mortality Weekly Report (MMWR)
29.07.2021
This report describes progress toward hepatitis B control in the World Health Organization European Region.
Morbidity and Mortality Weekly Report (MMWR)
8.07.2021
This report describes donor-derived hepatitis B virus infections after liver transplantation.
Morbidity and Mortality Weekly Report (MMWR)
3.09.2020
This report describes the prevalence of past or present infection with hepatitis B virus among adults by race and Hispanic origin during 1999-2018.
Morbidity and Mortality Weekly Report (MMWR)
27.08.2020
This report describes a funding program in Uzbekistan designed to identify and treat cases of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection at a lowered cost with the goal of meeting the World Health Organization's targets to eliminate HBC and HCV infection.
Morbidity and Mortality Weekly Report (MMWR)
30.07.2020
This report describes progress of countries in the World Health Organization's South-East Asia region toward reaching 90% hepatitis B vaccination coverage.
Morbidity and Mortality Weekly Report (MMWR)
25.06.2020
This report describes the June 2020 U.S. Public Health Service guidelines which recommend actions healthcare providers can take before and after transplant to minimize the risk of infection

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

www.infmed.dk
Version: 2.14.1
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.815 s

Cookies og privatliv